PVTX-405: Potent Selective IKZF2 Degrader for Immunotherapy
In a groundbreaking advance in cancer immunotherapy, researchers have unveiled PVTX-405, a novel molecular glue degrader that targets IKZF2 with ...
In a groundbreaking advance in cancer immunotherapy, researchers have unveiled PVTX-405, a novel molecular glue degrader that targets IKZF2 with ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine